ALK reaches symbolic milestone as tablets generate half of revenues
On Thursday, ALK published the best first quarterly report in the allergy company’s history, which also signaled a great future for tablet sales. ”Getting to the halfway point really does something to the company culture,” says CEO Carsten Hellmann.
by andreas lønstrup, translated by daniel pedersen
On Thursday, ALK-Abelló CEO Carsten Hellman could present a Q1 report that beat analysts’ growth predictions for the allergy firm’s revenue and operating profit.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK beats analyst expectations on all parameters
For subscribers
.jpg&w=384&q=75)
